Why ketamine is so effective at preventing suicide
Ketamine rapidly improves cognitive function, making those in suicidal crisis less likely to harm themselves
November 4, 2021
Ketamine rapidly improves cognitive function, making those in suicidal crisis less likely to harm themselves
Tryp Therapeutics Submits IND Application for Phase 2a Clinical Trial in Fibromyalgia San Diego, California–(Newsfile
Braxia Scientific Graduates First Cohort of Medical Professionals From Psilocybin-Assisted Therapy Training Program; Ready to
Cybin Announces Launch of EMBARK Psychedelic Facilitator Training Program Cybin (CYBN) is sending therapists on
Psychedelic Drug in Early Stages of Development Could Have Potential for Postpartum Depression Existing treatments
Agtech and KRTL Biotech Join Forces to Develop and Distribute Unique CBD and Psilocybin Products
Small Pharma granted fast-track designation from UK regulator for DMT-assisted therapy for Major Depressive Disorder
Open-label study of COMP360 psilocybin therapy for depression in cancer patients demonstrates feasibility of simultaneous
Field Trip Health Ltd. Continues Expansion With Psychedelic-Assisted Therapy Centers in Seattle, Vancouver and Fredericton Field
Mushroom Consumption May Lower Risk of Depression Even non-psychedelic mushrooms could lower your risk of
atai Life Sciences announces the launch of PsyProtix, to develop a precision psychiatry approach for
BLACKHAWK GROWTH’S MINDBIO THERAPEUTICS BRINGS DIGITAL MENTAL HEALTH TECHNOLOGY TO PSYCHEDELICS CLINICAL TRIALS Could microdosing
Blackhawk Growth’s MindBio Therapeutics Plans to Commercialize Intellectual Property Generated from the University of Auckland’s
Perception Neuroscience initiates Phase 2a study of PCN-101 (R-ketamine) for treatment resistant depression NEW YORK
Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for
Allied Corp. Advances Psilocybin Product Psilonex™ RX and Initiates Manufacturing Process Allied Corp. (ALID) has
Blackhawk Growth Subsidiary, MindBio Therapeutics, Accelerates Phase 1 & Phase 2 Microdosing Clinical Trials Vancouver,
Meet the women who regularly microdose psychedelics Three women struggling with mental health issues shared
Moms who microdose ‘magic’ mushrooms say the psychedelic made them better parents Moms around
Braxia Scientific to Commence Landmark Clinical Trial to Conduct Canada’s First Multiple-Dose Psilocybin Clinical Trial
This Psychedelics Stock Could Grow 300% In One Year Experts predict major growth for this
Minnesota Psychedelic Therapy Clinic, Institute for Integrative Therapies, Begins Offering Psychedelic Therapy in a Group
Cannabis Firm Plans South Africa IPO, Magic Mushroom Expansion South Africa’s first cannabis company is
Diamond Therapeutics Announces Health Canada Approval of Clinical Trial with Low-Dose Psilocybin There’s tremendous anecdotal